Company Filing History:
Years Active: 2018-2020
Title: Spiro Pavlopoulos: Innovator in N-acylethanolamine Hydrolyzing Acid Amidase Inhibitors
Introduction
Spiro Pavlopoulos is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for N-acylethanolamine hydrolyzing acid amidase (NAAA). With a total of 2 patents, his work is paving the way for advancements in therapeutic applications.
Latest Patents
Pavlopoulos's latest patents focus on N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their applications. The compounds he has developed are represented as Formula I, which includes tautomeric and stereoisomeric forms, as well as pharmaceutically acceptable salts. These compounds serve as inhibitors of NAAA, which is crucial for treating conditions mediated by this enzyme. His research is directed towards creating effective compounds, compositions, and methods to inhibit NAAA and address related medical conditions.
Career Highlights
Spiro Pavlopoulos is affiliated with Northeastern University, where he continues to engage in innovative research. His work has garnered attention in the scientific community, contributing to the understanding and potential treatment of various health conditions.
Collaborations
Pavlopoulos collaborates with esteemed colleagues, including Michael Sotirios Malamas and Alexandros Makriyannis. Their combined expertise enhances the research efforts in the field of biochemistry and pharmacology.
Conclusion
Spiro Pavlopoulos is a prominent figure in the development of N-acylethanolamine hydrolyzing acid amidase inhibitors. His innovative work at Northeastern University is making strides in the treatment of conditions related to NAAA.